Bob G. Gower - Dec 9, 2022 Form 4 Insider Report for Ensysce Biosciences, Inc. (ENSC)

Role: Director
Signature: /s/ Bob G Gower
Stock symbol: ENSC
Transactions as of: Dec 9, 2022
Transactions value $: $500,000
Form type: 4
Date filed: 2/1/2023, 05:06 PM
Previous filing: Jun 27, 2022
Next filing: Mar 2, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ENSC	Common Stock	Purchase	$500K	+357K	+90.2%	$1.40	753K	Dec 9, 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ENSC	Warrants	Award		+714K	+34357.19%		716K	Dec 9, 2022	Common Stock	714K	$1.40	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On October 28, 2022, Ensysce Biosciences, Inc. (the "Company"), pursuant to an amendment to the Company's Third Amended and Restated Certificate of Incorporation, effectuated a one-for-twenty reverse stock split of the Company's common stock, par value $0.0001 (the "Common Stock").
F2	On December 9, 2022, Mr. Gower purchased 357,143 shares of Common Stock at a price of $1.40 per share.
F3	On December 9, 2022, Mr. Gower purchased 357,143 warrants to purchase 714,286 shares of Common Stock with an exercise price of $1.40 per share (the "Warrants") in an underwritten offering further described on the Company's Prospectus filed pursuant to Rule 424(b)(4) (File No. 333-268038) filed with the Commission on December 9, 2022. The Warrants are immediately exercisable and may be exercised until five years from the date of issuance.